C. Barranger

OriGene (United States)

Papers

1

Total Citations

28

H-Index

1

About

C. Barranger is a prominent researcher in clinical virology and molecular diagnostics, with a particular focus on Epstein-Barr virus (EBV) detection and quantification. Their seminal work, "Evaluation of the Epstein-Barr Virus R-Gene Quantification Kit in Whole Blood with Different Extraction Methods and PCR Platforms" (2007), has garnered 28 citations and stands as a key contribution to the field. This study systematically assessed the performance of a commercial EBV quantification kit across multiple extraction techniques and PCR platforms, providing critical insights into assay standardization and reliability for viral load monitoring. Barranger’s research has directly impacted clinical practice by improving the accuracy and reproducibility of EBV diagnostics, essential for managing transplant patients and EBV-associated malignancies. Their work demonstrates a commitment to bridging laboratory methodology and clinical application, ensuring that molecular tools are robust and transferable across settings. Through this foundational study, Barranger has helped establish benchmarks for viral quantification, influencing subsequent research and diagnostic guidelines. Their contributions continue to support the advancement of precision medicine in infectious disease management.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
Evaluation of the Epstein-Barr Virus R-Gene Quantification Kit in Whole Blood with Different Extraction Methods and PCR Platforms
28 citations · 2007
📈 Most Prolific Year: 2007 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: OriGene (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago